REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 45 filers reported holding REPROS THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 0.15 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $0 | – | 400 | +166.7% | 0.00% | – |
| Q3 2017 | $0 | – | 150 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | – | 150 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | – | 150 | 0.0% | 0.00% | – |
| Q4 2016 | $0 | – | 150 | 0.0% | 0.00% | – |
| Q3 2016 | $0 | – | 150 | 0.0% | 0.00% | – |
| Q2 2016 | $0 | -100.0% | 150 | -84.6% | 0.00% | – |
| Q1 2016 | $1,000 | 0.0% | 975 | 0.0% | 0.00% | – |
| Q4 2015 | $1,000 | -93.8% | 975 | -54.4% | 0.00% | – |
| Q3 2015 | $16,000 | +100.0% | 2,140 | +86.1% | 0.00% | – |
| Q2 2015 | $8,000 | -20.0% | 1,150 | 0.0% | 0.00% | – |
| Q1 2015 | $10,000 | -9.1% | 1,150 | 0.0% | 0.00% | – |
| Q4 2014 | $11,000 | -35.3% | 1,150 | -33.9% | 0.00% | – |
| Q3 2014 | $17,000 | +142.9% | 1,740 | +335.0% | 0.00% | – |
| Q2 2013 | $7,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. | 778,800 | $935,000 | 0.18% |
| Allegis Investment Advisors, LLC | 366,190 | $439,000 | 0.12% |
| GENERAL AMERICAN INVESTORS CO INC | 589,768 | $708,000 | 0.07% |
| Acrospire Investment Management LLC | 24,881 | $30,000 | 0.02% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 114,165 | $137,000 | 0.00% |
| Mariner Wealth Advisors-Cincinnati, LLC | 11,000 | $13,000 | 0.00% |
| Renaissance Technologies | 727,113 | $873,000 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 1,750 | $2,000 | 0.00% |
| VANGUARD GROUP INC | 889,850 | $1,068,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 150 | $0 | 0.00% |